Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2026-01-20 @ 5:17 PM
Study NCT ID:
NCT01937806
Status:
UNKNOWN
Last Update Posted:
2020-01-27
First Post:
2013-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 and Extensional Study of Besifovir
Sponsor:
IlDong Pharmaceutical Co Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2016-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01
Completion Date Type:
ESTIMATED
First Submit Date:
2013-09-04
First Submit QC Date:
None
Study First Post Date:
2013-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-23
Last Update Post Date:
2020-01-27
Last Update Post Date Type:
ACTUAL